BioSpace News Archive

AlzeCure Pharma AB announced that it has received acceptance of a late breaking abstract presentation at the AAT- AD/PD conference, which this year will be kept completely digital on 2-5 April 2020 as a result of the corona virus.

Kodiak Sciences Inc. today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2019 .

Company remains on track to complete submission by the end of the second quarter 2020 -

Recognition reinforces baricitinib’s potential to be the first FDA-approved medicine for individuals living with alopecia areata

Industrie De Nora S.p.a. (De Nora), is supporting the efforts of the Civil Protection Department by deploying four electrochlorination systems in northern Italy, near Milan.

Applied Genetic Technologies Corporation (Nasdaq: AGTC), today announced that it has completed the planned enrollment in all dose groups for adult patients (age 18 years or older), including the two higher dose groups, of its Phase 1/2 clinical programs with achromatopsia due to mutation in the ACHM CNGB3 or ACHM CNGA3 genes.

Acquisition Expected to Have a Total Purchase Price of Approximately US$76 Million Including the Repayment of Certain Correvio Indebtedness ADVANZ PHARMA Intends to Pay for the Acquisition with Cash on Hand Provides ADVANZ PHARMA with an Immediate and Direct Commercial Presence in Germany , France , Spain , Italy , and the Benelux reg

BioNTech SE provides further details on the Company’s R&D effort, “Project Lightspeed”, to develop a potential vaccine to induce immunity and prevent COVID-19 infection in response to the growing global health threat posed by the disease.

CASI Pharmaceuticals today reported financial results for the year ended December 31, 2019.

Mark Tryniski to Stand for Reelection as Director but Will Not Stand for Reappointment as Chair